Clinical Trial Update: Safety, Feasibility, and Tolerability of Sulforaphane in Children with Chronic Kidney Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing the safety, feasibility, and tolerability of sulforaphane in children with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Sulforaphane (sulforaphane)

Snippet

Sponsor: University of Rochester | Conditions: Pediatric Kidney Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING